Second-line systemic treatment for metastatic colorectal cancer: A systematic review and Bayesian network meta-analysis based on RCT.
<h4>Background</h4>The optimal second-line systemic treatment for metastatic colorectal cancer (mCRC) is inconclusive.<h4>Methods</h4>We searched PubMed, Web of Science, EMBASE, and Cochrane Library for RCTs comparing second-line systemic treatments for mCRC from the inceptio...
Saved in:
| Main Authors: | Chengyu Sun, Enguo Fan, Luqiao Huang, Zhengguo Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0313278 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
by: N. A. Avxentyev, et al.
Published: (2016-09-01) -
Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials
by: R.-D. Hofheinz, et al.
Published: (2016-01-01) -
Efficacy and safety of oxaliplatin-based chemotherapy as first-line treatment in elderly patients with metastatic colorectal cancer: a meta-analysis
by: Shaoqing Fan, et al.
Published: (2025-04-01) -
Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma.
by: Gabriel Tremblay, et al.
Published: (2019-01-01) -
Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers
by: Ana Fernández Montes, et al.
Published: (2019-03-01)